Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease

Clinical trial NCT06917664 · RECRUITING

Trial details

NCT number: NCT06917664
Sponsor: China National Center for Cardiovascular Diseases
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease Ischemic Mitral Regurgitation Angiotensin Receptor/Neprilysin Inhibitor

Start date: 2025-06-05
Primary completion: 2026-12-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.